Could adding extra chemo before standard therapy beat nasopharyngeal cancer?

NCT ID NCT05979961

Ongoing Disease control Sponsor: Sun Yat-sen University Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial is testing whether giving an extra round of chemotherapy before the usual chemoradiotherapy can improve outcomes for people with a certain type of nasopharyngeal cancer. Participants will either receive standard chemoradiotherapy alone or induction chemotherapy (gemcitabine and cisplatin) followed by the same chemoradiotherapy. The study aims to see if the added chemo helps delay cancer progression or relapse.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: gemcitabine and cisplatin (induction chemotherapy) plus concurrent chemoradiotherapy (IMRT and cisplatin)
What this could lead to: If adding induction chemotherapy before standard chemoradiotherapy improves progression-free survival, it could become a new standard for low-risk nasopharyngeal carcinoma, potentially reducing recurrence and improving outcomes.
What could go wrong: This is a phase 3 trial, but results are not yet known. Adding chemotherapy may increase side effects without improving survival, and the benefit may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nasopharyngeal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NASOPHARYNGEAL CARCINOMA

Contacts and locations

Locations

Cancer Hospital of Guizhou Province

Guiyang, Guizhou, China
Guangzhou Panyu Central Hospital

Guangzhou, Guangdong, China
Hunan Cancer Hospital

Changsha, Hunan, China
Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi, 530021, China
Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology

Wuhan, Hubei, China
Union Hospital, Tongji Medical College,Huazhong University of Science and Technology;

Wuhan, Hubei, China
Zhongshan City People's Hospital

Zhongshan, Guangdong, 528499, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.